Key result
A single oral dose of minoxidil increased cardiac index from 2.34 to 2.95 l/min/m2 and reduced systemic vascular resistance in patients with chronic left ventricular failure.
Why the study?
Does a single oral dose of minoxidil improve acute hemodynamics in patients with chronic left ventricular failure?
Observational (n=18)
Does a single oral dose of minoxidil improve acute hemodynamics in patients with chronic left ventricular failure?
A single oral dose of minoxidil acutely improves cardiac index and reduces systemic vascular resistance in patients with chronic left ventricular failure.
Answers are grounded in this paper and cite their sources.
Acute hemodynamic effects of minoxidil in chronic LV failure are hypothesis-generating; randomized trials needed before clinical adoption.
Vasodilators used in chronic congestive heart failure are not optimal in that nitrates are predominant venodilators, prazosin is associated with tolerance development, and hydralazine produces chronic toxicity. Therefore, we studied the acute hemodynamic effects of a single dose of minoxidil in 18 patients with chronic left ventricular failure caused by ischemic or primary cardiomyopathy. Peak effects were observed 5 hours after single oral doses of minoxidil, averaging 15.3 +/- 1.4 mg (SEM). Heart rate rose slightly, from 85.4 +/- 2.9 to 90.9 +/- 3.2 beats/min, after minoxidil (p less than 0.02) and mean arterial pressure fell slightly, from 88.0 +/- 2.3 to 84.9 +/- 2.5 mm Hg (p less than 0.05). Cardiac index increased from 2.34 +/- 0.l4 to 2.95 +/- 0.29 l/min/m2 after minoxidil (p less than 0.02) and systemic vascular resistance fell from 19.6 +/- 1.5 to 15.0 +/- 1.3 units (p less than 0.01). Minoxidil did not affect right atrial, pulmonary arterial and pulmonary wedge pressures. Hemodynamic effects of minoxidil persisted for at least 8 hours after a single dose. Minoxidil appears to be an effective arterial dilating agent in patients with heart failure and resembles hydralazine in its actions. Because of its potency, prolonged duration of action and relatively low toxicity, minoxidil may be a useful vasodilator for heart failure. However, its long-term effect must be further evaluated.
No takes yet. Share an insight, caveat, or question.
Franciosa et al. (1981) conducted an observational in chronic left ventricular failure (n=18). minoxidil was evaluated on acute hemodynamic effects (cardiac index and systemic vascular resistance). A single oral dose of minoxidil increased cardiac index from 2.34 to 2.95 l/min/m2 and reduced systemic vascular resistance in patients with chronic left ventricular failure.
Synapse has enriched 10 related papers. Consider them for comparative context: